SCHEMBL22650403

SCHEMBL22650403

CC(C)n1cnc2c(OC(F)F)nc(-c3ccnc(Cl)n3)cc21

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
PDE8A O60658 3/20 0.34
PDE2A O00408 1/20 0.34
PDE4D Q08499 1/20 0.34
KCNH2 Q12809 1/20 0.34
PDE10A Q9Y233 1/20 0.34
CCNA2 P20248 7/20 0.33
CDK2 P24941 7/20 0.33
CCNA1 P78396 7/20 0.33
CDK5 Q00535 6/20 0.33
CDK5R1 Q15078 6/20 0.33
DYRK1A Q13627 5/20 0.33
L3MBTL1 Q9Y468 4/20 0.32
HTR3A P46098 1/20 0.31
APAF1 O14727 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
CDK1 P06493 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22650407 0.87 L3MBTL1 (0.37) MAPK14SMN1; SMN2PDE8APDE2APDE4D
SCHEMBL29491131 0.82 MAPK14 (0.40) MAPK14SMN1; SMN2PDE8APDE2APDE4D
SCHEMBL22650600 0.82 MAPK14 (0.40) MAPK14SMN1; SMN2PDE8APDE2APDE4D
SCHEMBL29491141 0.80 SMN1; SMN2 (0.37) MAPK14SMN1; SMN2CCNA2CDK2CCNA1
SCHEMBL22650503 0.74 MAPK14 (0.46) MAPK14SMN1; SMN2CCNA2CDK2CCNA1
SCHEMBL22650721 0.69 SMN1; SMN2 (0.34) SMN1; SMN2CCNA2CDK2CCNA1CDK5
SCHEMBL22650827 0.68 CDK4 (0.39) CDK2CDK1
SCHEMBL30038555 0.68 MAPK14 (0.42) MAPK14SMN1; SMN2CDK2DYRK1ACDK1
SCHEMBL19836336 0.68 MAPK14 (0.42) MAPK14SMN1; SMN2CDK2DYRK1ACDK1
SCHEMBL22650362 0.65 CDK4 (0.36) CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020224568-A1 CDK INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2020-11-12 WO disclosed